Janus Henderson Group
DMRA

Janus Henderson Group’s Damora Therapeutics DMRA Stock Holding History

Janus Henderson Group’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.4M Buy
2,362,696
+2,360,957
+135,765% +$60.7M 0.03% 368
2025
Q4 		$40M Buy
+1,739
New +$30.2K 0.02% 455
2022
Q2 		– Sell
-28,981
Closed -$1.59M – 2631
2022
Q1 		$1.59M Sell
28,981
-1,409
-5% -$79.1K ﹤0.01% 1311
2021
Q4 		$2.3M Sell
30,390
-21,050
-41% -$1.65M ﹤0.01% 1229
2021
Q3 		$4.5M Sell
51,440
-540
-1% -$57.7K ﹤0.01% 1082
2021
Q2 		$6.41M Sell
51,980
-897
-2% -$122K ﹤0.01% 1012
2021
Q1 		$7.83M Sell
52,877
-546
-1% -$149K ﹤0.01% 937
2020
Q4 		$15.9M Buy
+53,423
New +$19.9M 0.01% 790

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Janus Henderson Group's DMRA Position: Q1 2026 in Review

Janus Henderson Group increased its Damora Therapeutics (DMRA) stake by 135,765% in Q1 2026, buying an estimated $60.7M and bringing the position to 2,362,696 shares worth $61.4M. The position accounts for 0.03% of the portfolio, ranked #368.

Janus Henderson Group first reported a position in DMRA in Q4 2020 and has held it in 8 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • Janus Henderson Group held 2,362,696 shares of Damora Therapeutics worth $61.4M as of Q1 2026.
  • Janus Henderson Group bought 2,360,957 Damora Therapeutics shares in Q1 2026, an estimated $60.7M.
  • Damora Therapeutics made up 0.03% of Janus Henderson Group's portfolio in Q1 2026, its #368 holding.
  • Janus Henderson Group first reported a position in Damora Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.